ColorPDF

Black/White


Return



The hydroxychloroquine controversy for COVID-19: A review of the statistical evidence


Abstract: At the onset of the COVID-19 pandemic, as early as March 2020, a hydroxychloroquine/azithromycin combination therapy was proposed by Raoult and colleagues (IHU, Marseilles, France) based on preliminary viral clearance results. In the United States, this treatment protocol was further enhanced into a hydroxychloroquine, azithromycin, zinc triple-drug therapy by Dr. Vladimir Zelenko (Kiryas Joel, NY, USA) with early reports of positive outcomes, and subsequently evolved into the sequenced McCullough protocol. In this talk, I will review the statistical evidence that emerged from both Zelenko and Raoult, supporting the efficacy of hydroxychloroquine-based combination therapies, when initiated early at the onset of infection, and my involvement in some of these studies. I will also comment on a meta-analysis of Indian studies on the prophylactic use of hydroxychloroquine and zinc and some of the controversies that have emerged.